Jiangzhong pharmaceutical: it is estimated that the total operating revenue in the first quarter of 2022 will be about 890 million yuan, with a year-on-year increase of about 30%

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Five Startups Awarded in MYCentre4IR-Bursa Malaysia ESG Innovation Challenge 2024

Highlighting the Role of Innovation in Achieving Sustainability and Business Goals Powered by UpLink, the World Economic Forum's Open Innovation Platform

Doubt Cast on Singapore’s Effort to Preserve Hawker Culture

A new initiative allowing certain foreigners to work as food stall assistants in Singapore’s hawker trade may face challenges in attracting applicants due to the physically demanding nature of the job and its relatively low wages, policy experts suggest.

Brazil raises import tariffs on optical cables, initiates anti-dumping probe

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?